Target intelligence / Profile preview

Thrombospondin type-1 domain-containing protein 4 (THSD4)

Target
THSD4
Molecular classification
Extracellular matrix structural constituent, ADAMTS-like (ADAMTSL) protein, Secreted glycoprotein, Other
01

Overview

Thrombospondin type-1 domain-containing protein 4 (THSD4) is a secreted, non-enzymatic glycoprotein of the ADAMTS-like (ADAMTSL) family that functions as a key extracellular matrix (ECM) structural constituent. THSD4 physically interacts with fibrillin-1, facilitating microfibril assembly crucial for tissue elasticity and integrity in organs such as the aorta, skin, and bone. It plays roles in pulmonary physiology, bone mass regulation, and is implicated as a modulator in the tumor microenvironment of colorectal cancer, restraining TGF-β signaling and cancer metastasis. In the skin, THSD4 supports hair growth by mediating interactions between the dermal papilla and hair matrix, playing a central role in age-related ECM remodeling. Mutations in THSD4 are associated with familial thoracic aortic aneurysm, aortic dissection, and may influence susceptibility to osteoporosis and cancer progression[1][2][3][4][5].

Other names
ADAMTS-like protein 6ADAMTSL-6ADAMTSL6A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6FVSY9334PRO34005FLJ13710AAT12
02

Mechanism of action

Not targeted by approved drugs; mechanisms relate to promoting microfibril assembly through interaction with fibrillin-1 and attenuation of TGF-β signaling, potentially via sequestration of active/latent TGF-β complexes[4][1][3].

03

Biological functions

Microfibril assemblyRegulation of extracellular matrix (ECM) integrityModulation of TGF-β signalingEpidermal-mesenchymal interactionHair growth promotionPulmonary function modulationBone mass regulation
04

Disease associations

Thoracic aortic aneurysmFamilial thoracic aortic aneurysm and aortic dissectionOsteoporosisColorectal cancer (tumor microenvironment modulation)Hair growth disorders (including age-related hair loss)
05

Safety considerations

Mutations may impair ECM integrity, predisposing to vascular and skeletal diseases (not related to therapeutic intervention, but disease risk)[3][4].
06

Biomarkers

Genetic variants used in risk stratification for thoracic aortic aneurysm and bone mineral density[1].Expression levels potentially relevant in colorectal cancer microenvironment and age-related hair loss[1][2][3][5].

Beyond the preview

Go deeper on Thrombospondin type-1 domain-containing protein 4 (THSD4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thrombospondin type-1 domain-containing protein 4 (THSD4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call